Rutgeerts P - Search Results

1

Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease.

Rector A, Lemey P, Laffut W, Keyaerts E, Struyf F, Wollants E, Vermeire S, Rutgeerts P, Van Ranst M. Rector A, et al. Among authors: rutgeerts p. Genes Immun. 2001 Oct;2(6):323-8. doi: 10.1038/sj.gene.6363784. Genes Immun. 2001. PMID: 11607788

2

Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease.

Rector A, Vermeire S, Thoelen I, Keyaerts E, Struyf F, Vlietinck R, Rutgeerts P, Van Ranst M. Rector A, et al. Among authors: rutgeerts p. Hum Genet. 2001 Mar;108(3):190-3. doi: 10.1007/s004390100462. Hum Genet. 2001. PMID: 11354628

3

Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.

Vijgen L, Van Gysel M, Rector A, Thoelen I, Esters N, Ceelen T, Vangoidsenhoven E, Vermeire S, Rutgeerts P, Van Ranst M. Vijgen L, et al. Among authors: rutgeerts p. Genes Immun. 2002 Nov;3(7):400-6. doi: 10.1038/sj.gene.6363888. Genes Immun. 2002. PMID: 12424621

4

Current status of genetics research in inflammatory bowel disease.

Vermeire S, Rutgeerts P. Vermeire S, et al. Among authors: rutgeerts p. Genes Immun. 2005 Dec;6(8):637-45. doi: 10.1038/sj.gene.6364257. Genes Immun. 2005. PMID: 16107869 Review.

5

C-reactive protein as a marker for inflammatory bowel disease.

Vermeire S, Van Assche G, Rutgeerts P. Vermeire S, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2004 Sep;10(5):661-5. doi: 10.1097/00054725-200409000-00026. Inflamm Bowel Dis. 2004. PMID: 15472532 Review.

6

Crohn's disease and month of birth.

Van Ranst M, Joossens M, Joossens S, Van Steen K, Pierik M, Vermeire S, Rutgeerts P. Van Ranst M, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2005 Jun;11(6):597-9. doi: 10.1097/01.mib.0000163697.34592.d4. Inflamm Bowel Dis. 2005. PMID: 15905708

7

Adalimumab in Crohn's disease.

Van Assche G, Vermeire S, Rutgeerts P. Van Assche G, et al. Among authors: rutgeerts p. Biologics. 2007 Dec;1(4):355-65. Biologics. 2007. PMID: 19707306 Free PMC article.

8

Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease).

Ferrante M, D'Haens G, Rutgeerts P, Vermeire S, Van Assche G. Ferrante M, et al. Among authors: rutgeerts p. Curr Gastroenterol Rep. 2009 Dec;11(6):504-8. doi: 10.1007/s11894-009-0076-5. Curr Gastroenterol Rep. 2009. PMID: 19903427 Review.

9

[Drug prevention of Crohn disease recurrence in the neo-terminal ileum after ileocolic resection].

Vermeire S, Rutgeerts P. Vermeire S, et al. Among authors: rutgeerts p. Zentralbl Chir. 1998;123(4):352-6. Zentralbl Chir. 1998. PMID: 9622893 Review. German.

10

Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity.

Vermeire S, Peeters M, Vlietinck R, Parkes M, Satsangi J, Jewell D, Rutgeerts P. Vermeire S, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2000 Aug;6(3):165-70. doi: 10.1097/00054725-200008000-00002. Inflamm Bowel Dis. 2000. PMID: 10961588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

727 results

Search Page